 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | CAR.B7-H3 T / UNC Lineberger Comprehensive Cancer Center
Trial initiation date, CAR T-Cell Therapy: Autologous CAR-T Cells Targeting B7-H3 in PDAC (clinicaltrials.gov) - Jul 17, 2024
P1, N=27, Not yet recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center
Initiation date: Jun 2024 --> Sep 2024
- | CAR.B7-H3 T / UNC Lineberger Comprehensive Cancer Center
Trial initiation date, CAR T-Cell Therapy: Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells (clinicaltrials.gov) - Apr 11, 2024
P1, N=27, Not yet recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center
Initiation date: Jun 2024 --> Sep 2024 Initiation date: Mar 2024 --> Jul 2024
- || CAR.B7-H3 T / UNC Lineberger Comprehensive Cancer Center
New P1 trial, CAR T-Cell Therapy: Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells (clinicaltrials.gov) - Apr 3, 2024
P1, N=42, Not yet recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center
- | CAR.B7-H3 T / UNC Lineberger Comprehensive Cancer Center
New P1 trial, CAR T-Cell Therapy: Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells (clinicaltrials.gov) - Mar 12, 2024
P1, N=27, Not yet recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center
- | CAR.B7-H3 T / UNC Lineberger Comprehensive Cancer Center
Enrollment open, Trial primary completion date, CAR T-Cell Therapy: Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc (clinicaltrials.gov) - Sep 10, 2022
P1, N=36, Recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center
Initiation date: Mar 2024 --> Jul 2024 Not yet recruiting --> Recruiting | Trial primary completion date: May 2030 --> Oct 2024
- | CAR.B7-H3 T / UNC Lineberger Comprehensive Cancer Center
New P1 trial, CAR T-Cell Therapy: Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc (clinicaltrials.gov) - May 8, 2022
P1, N=36, Not yet recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center
- | CAR.B7-H3 T / UNC Lineberger Comprehensive Cancer Center
Enrollment open, Trial initiation date, CAR T-Cell Therapy: Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian (clinicaltrials.gov) - Feb 20, 2021
P1, N=21, Recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center
Not yet recruiting --> Recruiting | Trial primary completion date: May 2030 --> Oct 2024 Not yet recruiting --> Recruiting | Initiation date: Dec 2020 --> Mar 2021
- | CAR.B7-H3 T / UNC Lineberger Comprehensive Cancer Center
New P1 trial, CAR T-Cell Therapy: Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian (clinicaltrials.gov) - Dec 16, 2020
P1, N=21, Not yet recruiting, Sponsor: UNC Lineberger Comprehensive Cancer Center